Effect of fetal dexamethasone exposure on the development of adult insulin sensitivity in a rat model

References

• Olsen J. Prenatal exposures and long term health effects. Epid Rev 2000; 22: 76–81
   PubMed Web of Science ®Google Scholar
• Matthews S. Fetal glucocorticoid exposure and hypothalamo-pituitary–adrenal function after birth. Endocr Res 2004; 30: 827–836
   PubMed Web of Science ®Google Scholar
• Dalziel S. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-Year follow-up of a randomized controlled trial. Lancet 2005; 365: 1856–1862
   PubMed Web of Science ®Google Scholar
• Barker D J. Fetal origins of coronary heart disease. BMJ 1995; 311: 171–174
   PubMed Web of Science ®Google Scholar
• Smith J T, Waddell B J. Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 2000; 141: 2422–2488
   PubMed Web of Science ®Google Scholar
• Nyrienda M J, Lindsay R S, Kenyon C J, Burchell A, Seckl J R. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998; 101: 2174–2181
   PubMed Web of Science ®Google Scholar
• Jansson T, Lambert G W. Effect of intrauterine growth restriction on blood pressure, glucose intolerance and sympathetic nervous system activity in the rat at 3–4 months of age. J Hypertens 1999; 17: 1239–1248
   PubMed Web of Science ®Google Scholar
• Moss T J, Sloboda D M, Gurrin L C, Harding R, Challis J R, Newham J P. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Com Physiol 2001; 281: 960–970
   Web of Science ®Google Scholar
• Collison M, Campbell I W, Salt I P, Dominiczak A F, Connell J M, Lyall H, Gould G W. Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins. Diabetologia 2000; 443: 1374–1380
   Google Scholar
• LeRoith D, Werner H, Beitner-Johnson D, Roberts C T, Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995; 16: 143–163
   PubMed Web of Science ®Google Scholar
• Rordorf-Nikolic T, Van Horn D J, Chen D, White M, Backer J. Regulation of phosphatidylinositol 3-kinase by tyrosyl phosphoproteins. J Biol Chem 1995; 270: 3662–3666
   PubMed Web of Science ®Google Scholar
• White M F. The insulin signaling system and the IRS proteins. Diabetologia 1997; 40: S2–7
   PubMed Web of Science ®Google Scholar
• Boney C, Smith R, Gruppuso P. Modulation of insulin-like growth factor-I mitogenic signaling in 3T3-L1 preadipocyte differentiation. Endocrinology 1998; 139: 1638–1644
   PubMed Web of Science ®Google Scholar
• Hales C N, Barker D P. Type 2 diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992; 35: 595–602
   PubMed Web of Science ®Google Scholar
• Purdy L P, Metzger B E. Influences of intrauterine metabolic environment on adult disease: What may we infer from size at birth. Diabetologia 1996; 39: 1126–1130
   PubMed Web of Science ®Google Scholar
• Shepherd P R, Withers D J, Siddle K. Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling. Biochem J 1998; 333: 471–490
   PubMed Web of Science ®Google Scholar
• Ueki K, Fruman D, Yballe C, Fasshauer M, Klein J, Asano T, Cantley L, Kahn R. Positive and negative roles of p85α and p85β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 2003; 48: 48 453–48 466
   Google Scholar
• Rajala R, Chan M, Tsiokas M, Leonidas R. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase. Biochemistry 2004; 43: 5637–5650
   PubMed Web of Science ®Google Scholar
• Bjornholm N, Kawano Y, Lehtihet M, Zierath J. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 1997; 46: 524–527
   PubMed Web of Science ®Google Scholar
• Maegawa H, Shigeta Y, Egawa K, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991; 40: 815–819
   PubMed Web of Science ®Google Scholar
• Rondinone C. Insulin receptor substrate is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1997; 94: 4171–4175
   PubMed Web of Science ®Google Scholar
• Cusi K, Maezono K, Osman A, Pendergrass M, Patti M E, Pratipanawatr T, Defronzo R A, Kahn C R, Mandarino L J. Insulin resistance differentially affects the PI 3-kinase and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311–320
   PubMed Web of Science ®Google Scholar
• Whitehead J P, Clark S F, Urso B, James D E. Signalling through the insulin receptor. Curr Opin Cell Biol 2000; 12: 222–228
   PubMed Web of Science ®Google Scholar
• Pessin J, Saltiel A. Signaling pathways in insulin action: Molecular targets of insulin resistance. J Clin Invest 2000; 106: 165–170
   PubMed Web of Science ®Google Scholar
• Wang Q. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999; 4008–4018
   PubMed Web of Science ®Google Scholar
• Cong L N. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol 1997; 11: 1881–1890
   PubMedGoogle Scholar